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Summary Pancreatic ductal adenocarcinomas are characterised by a dense connective tissue reaction. To test
the hypothesis that stroma components are synthesised and produced by the tumour cells themselves, eight cell
lines as well as six xenografted tumours from human ductal adenocarcinomas of the pancreas were examined
for the expression of extracellular matrix proteins (ECM), using cDNA probes and antibodies to collagen
types I, III and IV, vitronectin, fibronectin, undulin and laminin. All tumour cell lines (CAPAN-1, CAPAN-2,
AsPC-1, BxPC-3, PANC-1, PaCa-2, PaCa-3, PaCa-44) and xenografted human pancreatic tumours expressed
at least one of the examined ECM at the RNA (collagen type IV> laminin = fibronectin = vitronectin> col-
lagen type III> undulin> collagen type I) or protein level (collagen type IV = collagen type III> vitronec-
tin> laminin> collagen type I = fibronectin> undulin). In nude mouse tumours expression of laminin and
collagen I was most pronounced in well-differentiated carcinomas. In a few tumours, collagen type III,
vitronectin and undulin were expressed on the luminal side of the neoplastic glands, suggesting loss of normal
polar differentiation. Incubation with fetal calf serum modulated ECM RNA levels to a varying extent in all
but one cell line (AsPC-1). The results suggest that human pancreatic ductal adenocarcinomas cells are capable
of synthesising and producing extracellular matrix proteins in vitro and in vivo, but that the extent and pattern
of ECM expression differs between the various tumours and conditions tested.
Well-differentiated ductal adenocarcinomas of the pancreas
show abundant dense stroma, usually intact basal membranes
and regular laminin deposits, while these features are either
inconspicuous or even absent in poorly differentiated ductal
carcinomas of the pancreas (Kloppel & Fitzgerald, 1986;
Kloppel et al., 1985). The factors which determine the
stromal development in these pancreatic carcinomas are not
known. Immunocytochemical, radioimmunological and bio-
chemical in vivo and in vitro studies have indicated that
tumours of epithelial origin, including pancreatic carcinoma,
have the potential to produce extracellular matrix proteins
(ECM), notably laminin (Haglund et al., 1984; 1989; Alitalo
et al., 1981; Haberern-Blood et al., 1987; Mahlbacher et al.,
1992) and that in cell cultures laminin appears to increase
tumour cell polarity and exocytosis (Mollenhauer et al.,
1987).
As these findings suggest a role for laminin and possibly
also other ECM in pancreatic carcinoma differentiation, it is
important to know whether the expression of ECM can be
indeed traced back to the RNA level of the tumours and
correlated to their morphology.
Our study therefore addressed the following questions: are
ductal pancreatic adenocarcinoma cells capable of producing
different components of the extracellular matrix in vitro and
in vivo?; is the expression influenced by the degree of tumour
differentiation?; and can the expression of ECM be
modulated by the tissue culture conditions?
Materials and methods
Tumour cell lines
Cell lines from human pancreatic ductal adenocarcinomas
were either obtained from ATCC (Bethesda, MD, USA)
(AsPC-l, BxPC-3, CAPAN-1, CAPAN-2, PANC-l) or
donated by J. Mollenhauer (Rush University, Chicago, IL,
USA) (PaCa-2, PaCa-3, PaCa-44). These cell lines have
already been described in detail (Kyriazis et al., 1982;
Haberern & Kupchik, 1985; Liehr et al., 1990; Mai et al.,
1990; Haberern-Blood et al., 1987; Kloppel et al., 1985). The
PaCa-2 and PaCa-3 cell lines were established from the cor-
responding nude mouse tumours (see below). The PaCa-2 cell
line has been renamed PaTu-II in some publications (Mai et
al., 1990). Cells were grown in the appropriate culture
medium (RPMI and DMEM respectively) containing 10%
fetal calf serum (FCS), supplemented with 1% penicillin and
1% streptomycin. Batches of the first expansion were frozen
down in order to obtain large stocks for all further
experiments. The purity of tumour cell lines with regard to
contamination by fibroblasts was monitored by phase-
contrast microscopy, haematoxylin and eosin (H&E) staining
and immunofluorescence for cytokeratin (Trautmann et al.,
1993; Rafiee et al., 1992).
For the serum deprivation studies, cells from confluent
monolayers were seeded in new tissue culture flasks in
medium containing 10% FCS. After 48 h, cells were washed
twice with sterile phosphate-buffered saline (PBS) and then
incuabted for 2-5 days in serum-free medium, depending on
the growth characteristics. RNA was then harvested from
proliferating cultures (see below).
Xenograftedpancreatic ductal adenocarcinomas
Freshly isolated tumour tissue was transplanted sub-
cutaneously on to nu/nu mice as described previously
(Kl6ppel et al., 1985; Giovanella & Fogh, 1985). The PaCa-2,
PaCa-3 and PaCa-39 tumours have been studied previously
(Kloppel et al., 1985). Tumour histology was checked after
the first passage and compared with that of the primary
tumour (Kloppel et al., 1985). For further studies, tumours
were grown for at least three passages, excised from the
anaesthetised animals and immediately frozen in liquid nit-
rogen. The histological differentiation of the tumours was
determined as previously described (Kl6ppel et al., 1985).
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RNA extraction
Preparation of RNA from fresh-frozen tissue and cultured
cells was carried out as described previously (Chirgwin et al.,
1979). In brief, minced tissue and cells were disintegrated by
ultrasound in the presence of a chaotropic agent (sodium
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dodecyl sulphate, SDS), mixed with guanidium thiocyanate
(GTC), subjected to centrifugation, extracted with phenol/
chloroform, precipitated and finally assessed for quality and
quantity by mini-gel electrophoresis and spectrophotometry
(Maniatis et al., 1982).
Slot-blot hybridisation and densitometry
RNA slot-blot analysis was performed as described
previously (Lohr & Oldstone, 1990). In brief, 25 jig RNA
aliquots were denatured at 65°C for 15 min in 6 x SSC
(1 x SSC = 0.15M sodium chloride, 0.015 M trisodium cit-
rate), 7.4% formaldehyde, then serially diluted in 15 x SSC.
Samples were applied to nitrocellulose membranes using a 72
slot mini-fold blot apparatus. Nitrocellulose membranes were
baked for 2 h at 80°C, prehybridised for 4 h at 37°C in 50%
deionised formamide, 5 x SSC, 2.5 x Denhardt's solution,
100 jig ml-' boiled, sonicated salmon sperm DNA, and then
hybridised for 24 h between 37°C and 42°C with the labelled
probes (see below). After hybridisation, membranes were
washed in 2 x SSC, 0.1% SDS, at 37°C for 30 min, in
0.1 x SSC, 0.1% SDS, at 55°C or 65°C for 30 min, then
exposed against Kodak XAR-5 film at - 70°C with Cronex
lighting plus an intensifying screen. Following exposure to
film, membranes were washed in 0.1 x SSC, 0.1% SDS, at
85°C for 2 h to remove cDNA hybrids. After re-exposure to
film to ensure efficient loss of hybridisation signal, mem-
branes were re-used in hybridisation experiments. Hybridisa-
tion experiments were performed at least twice with separate
RNA preparations for all cell lines and ECM probes.
For densitometry of the RNA from pancreatic tumours
transplanted to nude mice, films were scanned with an LKB
Ultrascan XL laser densitometer (LKB/Pharmacia, Sweden).
In order to maintain an internal standard for these
experiments and as an additional control to ensure that
mRNA levels were measured for equivalent amounts of total
cellular RNA, levels of ECM RNA were related to the
individual 28S ribosomal RNA levels (Lipkin et al., 1988;
Bowles et al., 1986). For each sample, the ratio of the ECM
hybridisation intensity to the ribosomal hybridisation signal
was calculated. These ratios were used to compare the
different gradings of each nude mice tumour and controls.
Beside the calculation of relative densities, the hybridisa-
tion signal is rated in a semiquantitative grading. A very
weak or absolutely no signal corresponding to densitometry
readings <0.100 was rated 0; a weak signal corresponding to
densitometry readings from 0.100 to 1.0 was rated 1; a signal
corresponding to densitometry readings from 1.0 to 5.0 was
rated 2; a signal corresponding to densitometry readings
5.0 was rated 3.
Probes
All cDNA probes were obtained as plasmids and trans-
formed in competent bacteria (Escherichia coli, DH5a)
(Maniatis et al., 1982). The probes encoded human specific
sequences within the DNA of the examined ECM. According
to sequence comparison analysis performed by the inves-
tigators these differ from the murine counterpart by
20-30%.
The collagen plasmids were a gift from E. Vuorio [collagen
types I (pHCALlU) (Makela et al., 1988) and III (pHFS3)
(Sandberg & Vuorio, 1987)] and D. Prockop, Jefferson,
Philadelphia, PA, USA (type IV, HT21; Pihlajaniemi et al.,
1985). The probe for fibronectin was donated by R.O. Hynes,
MIT, Cambridge, MA, USA (Schwarzbauer et al., 1983),
vitronectin by J. Smith, Scripps Clinic, La Jolla, CA, USA
(Seifert et al., 1991), undulin by D. Schuppan, Freie Univer-
sitat, Berlin, Germany (Just et al., 1991) and laminin (Bi-
chain) by J. Uitto, Jefferson University, Philadelphia, PA,
USA (Olsen et al., 1989). Control probes included onie to the
28S ribosomal RNA (S138, a gift from P. Southern, Univer-
sity of Minnesota, MN, USA; Lipkin et al., 1988) and one to
the ribosomal protein S6 (J. Kruppa, Hamburg, Germany;
Heinze et al., 1988). Probes were prepared by the random
hexoprimer method with 32P (Feinberg & Vogelstein, 1983),
yielding specific activities in the range of 5 x 108 c.p.m. iLg- .
For each hybridisation, 1-2 x 106c.p.m. probe per ml of
hybridisation mix was used.
Immunofluorescence
Cultured pancreatic tumour cells and cultured human fore-
skin fibroblasts as well as 5 jim thick cryostat sections of
xenografted human pancreatic carcinomas, and of normal
pancreatic tissue obtained from eight organ donors (Traut-
mann et al., 1993) were fixed in acetone at - 20°C for 10 min
and immunostained by indirect immunofluorescence. The
primary anbtibodies were against procollagen type I (car-
boxy-terminal, monoclonal mouse IgG,; Chemicon, Teme-
cula, CA, USA), collagen type III (polyclonal rabbit IgG;
Pasteur Diagnostika, Lyon, France), collagen type IV and
laminin (polyclonal rabbit-IgG; Heyl Chemie, Berlin, Ger-
many), fibronectin (cell-binding fragment, monoclonal mouse
IgGj; Boehringer, Mannheim, Germany), vitronectin (poly-
clonal rabbit IgG; J. Smith, Research Institute of Scripps
Clinic, La Jolla, CA, USA), undulin (monoclonal mouse
IgG2 kappa; Heyl Chemie) and cytokeratin [monoclonal,
mouse IgG; Boehringer (Trautmann et al., 1993)]. Unlabelled
primary antibodies were incubated with FITC-conjugated
rabbit-anti-mouse Ig, 5 jigml-' (Dakopatts, Copenhagen,
Denmark), and FLUOS-conjugated sheep anti-rabbit IgG,
F(ab')2 fragment, 10jigml-l (Boehringer). Immunostained
cells and tissue sections were embedded in antifade solution
(Johnson & de Nogueira Aranjo, 1981). Staining was per-
formed on at least two separate preparations for all tumour
cell lines or nude mouse tumours and all antibodies.
Immunocytochemistry
Cryostat sections of the xenografted pancreatic carcin-
omas were immunostained by the avidin-biotin-peroxidase
method (Dakopatts) as described previously (Lohr & Old-
stone, 1990). The primary antibodies different from those
listed above were against collagen type I (polyclonal rabbit
antiserum; Chemicon) and fibronectin (polyclonal rabbit IgG;
Dakopatts). As a secondary antibody, biotinylated goat anti-
rabbit IgG (Dakopatts) was employed at a 1:20 dilution.
Specificities and optimal working dilutions of antibodies
for both immunofluorescence and immunocytochemistry were
tested in tissue sections for normal pancreas and pancreatic
carcinomas. Staining patterns of ECM on this normal con-
trol pancreas were identical to those reported previously
(Uscanga et al., 1984). Controls included incubations with
rabbit and mouse gamma-globulins (6 and 8 jig of protein
per ml; Jackson Immunoresearch Lab., West Grove, PA,
USA) instead of the primary antibody as well as incubations
with the secondary antibody only. All polyclonal antibodies
were preabsorbed with the corresponding rodent ECM
according to the specifications of the manufacturers. Slides
were viewed and photographed with a Carl Zeiss 'Axiophot'
microscope. Staining of the tissue was graded semiquan-
titatively as follows: no staining was rated as 0 [if there were
very few cells positive (focus), this was noted separately];
weak staining intensity of all cells was rated 1, moderate
staining 2 and strong staining 3.
Electron microscopy
Cell lines in culture were fixed in 2.5% glutaraldehyde and
0.1% cacodylate buffer at pH 7.4, followed by fixation with
1% osmium tetroxide in the same buffer, and then pelleted,
dehydrated and embedded in Spurr's resin (Lohr et al.,
1989). For assessment of the ultrastructural differentiation of
the tumour cell lines, a modification of the grading system
described by Kern et al. (1986) was used. Experiments were
performed repeatedly on different samples and different pas-
sages of tumour cell lines.146 M. LOHR et al.
Results
Grade ofdifferentiation
Ultrastructural analysis revealed that the CAPAN-1 cell line
showed the characteristics of grade 1 tumour, the CAPAN-2,
BxPC-3, AsPC-l, PANC-1 cell lines those of grade 2 and the
PaCa-2, PaCa-3 and PaCa-44 cell lines those of grade 3. The
nude mouse tumours, KLE, PANK and PaCa-39, were
graded 1, SCHU graded 1-2 and PaCa-2 and PaCa-3 graded
3. In brief, grade 1 tumours were characterised by regularly
shaped nuclei, junctional complexes, numerous microvilli on
the cell surfaces and abundant apical mucin granules. Grade
2 tumours showed some irregularity of the nuclei, polytopic
distribution of microvilli, few mucin granules and vesicles
filled with membrane material. In grade 3 tumours, the cells
had polymorphous nuclei and abortive microvilli, but no
desmosomes or mucin granules. Contaminating fibroblasts
could not be detected in any of the cell lines.
RNA levels ofECM in tumour cell lines and nude mouse
tumours
RNA hybridisation signals of the pancreatic tumour cell lines
to ECM probes are shown in Figure 1a and the semiquan-
titative evaluation in Table I. For this analysis, all cell lines
were evaluated under culture conditions with FCS-containing
medium. All tumour cell lines showed RNA levels for col-
lagen type IV, 7/8 for laminin, 6/8 for fibronectin, 5/8 for
vitronectin and collagen type I, 3/8 for collagen type III and
2/8 for undulin (Figure la, Table I). In some instances, only
a
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Figure 1 Slot blot of RNA extracted from pancreatic tumour cell lines in tissue culture a, and from pancreatic carcinomas
transplanted to nude mice b, hybridised to extracellular matrix proteins (C I, C III, C IV, collagens type I, III, IV; FN, fibronectin;
VN, vitronectin; UN, undulin; LAM, laminin: S138, probe to ribosomal RNA). The lane of the original serial dilution slot blot
with 20pg of total RNA is shown in each case. FCS, fetal calf serum: RNA from cells cultured in the presence of FCS.
Plain = RNA from cells cultured in the absence of FCS (see text).
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Table I RNA and protein levels of extracellular matrix proteins in human pancreatic adenocarcinoma cell lines
Collagen I Collagen II Collagen III Fibronectin Vitronectin Undulin Laminin
Cell line Grade RNA Protein RNA Protein RNA Protein RNA Protein RNA Protein RNA Protein RNA Protein
CAPAN-1 1 1 0 oa 2 2 1 1 0 0 1 0 0 0 0
CAPAN-2 2 1 0 0 1 1 0 1 0 0 0 0 0 2 ob
AsPC-1 2 0 1-2 0 1-2 2 1 2 0 0 1-2 0 0 1 1-2
BxPC-3 2 3 0 3 1-2 2 1 2 0 3 1-2 2 0 2 0
PANC-1 2 2 0-2 0 1-2 2 2 2 0 2 1 0 0 3 1-2
PaCa-2 3 0 0 0 1 2 1 0 0 1 0 0 0 2 0
PaCa-3 3 0 0 2 1 2 OC 1 0 2 1 0 0 1 OC
PaCa-44 3 2 0 3 1-2 2 1 0 0 1 1 2 0 2 0
Fibroblasts Normal 2 2-3 3 1-2 2 OC 4 0 0 0 0 0 1 OC
0, negative; 1, weak positive; 2, moderate positive; 3, strong positive. aTrace amounts of RNA (see Figure la). bSingle cells moderately positive.
cSingle cells weakly positive. Note: all cell lines were cultivated in the presence of FCS.
trace RNA amounts of questionable significance could be
detected (Figure la, Table I). The relative densitometry
readings of the tumour cell RNA are shown in Table Ila.
There was no correlation between tumour grade and ECM
expression patterns.
Of the nude mouse tumours, 5/6 expressed collagen type
III and all type IV collagen, fibronectin, vitronectin, laminin
and undulin, but none collagen type I (Figure lb, Table III).
The relative densitometry readings of ECM of the nude
mouse tumour RNA are listed in Table Ilb. Grade 1 and 2
tumours expressed higher levels of fibronectin and collagen
type III than grade 3 tumours. Collagen type III, fibronectin,
undulin and vitronectin were all present at higher levels in
Table II Relative hybridisation densities (medians) of extracellular
matrix RNAs over ribosomal RNA (S138) in pancreatic carcinoma cell
lines (incubated with FCS) and nude mouse tumours grouped by
grading
a Cell lines
Probe
Col I
Col III
Col IV
FN
LAM
UN
VN
Grade 1-2
(n = 4)
1.26
0.53
2.22
0.62
0.43
0.13
0.26
Grade 3
(n = 4)
0.77
0.81
1.68
0.38
1.28
0.46
0.27
Fibroblasts
(n = 1)
1.91
28.98
2.19
12.81
0.54
12.75
0.00
b Nude mouse tumours
Grade 1-2 Grade 3 Pancreas Fibroblasts
Probe (n=4) (n=2) (n=3) (n= 1)
Col I 1.27 1.26 0.35 3.66
Col III 2.33 0.21 0.46 9.56
Col IV 0.70 0.58 2.32 3.80
FN 1.16 0.49 0.25 2.19
LAM 0.99 1.41 2.16 0.46
UN 1.19 1.47 0.13 1.19
VN 2.38 2.13 0.81 1.35
the grade 1 tumours compared with the normal pancreas
(Table Ilb).
ECM expression
Tables I and III summarise the staining results of the cul-
tured tumour cells and the nude mouse tumours. Positive
staining was demonstrated for several ECM in all cell lines or
nude mouse tumours. Seven of eight cell lines were positive
for collagen type IV and 4/8 for laminin; all were positive for
collagen type III, 6/8 for vitronectin, 2/8 for procollagen type
I (Figure 2), but all were negative for undulin and fibronec-
tin. Of the six tumours transplanted into nude mice, all
tumours were positive for type IV collagen and 4/6 for
laminin; all stained positive for type III collagen, fibronectin
and vitronectin, 4/6 were positive for collagen type I and 3/6
were positive for undulin (Table III). Staining for laminin
and collagen type I was related to the tumour grade (Table
III, Figure 3). In addition to the expression of ECM on the
basal site of the tumour cells, collagen type III, vitronectin
and undulin were expressed on the luminal/apical side of the
cells in some of the tumours (Figure 4). Staining of normal
control pancreas with all antibodies revealed linear deposits
of basement and interstitial ECM components, as has been
reported (data not shown) (Uscanga et al., 1984).
Modulation ofECM expression by FCS
Incubation of tumour cells with and without FCS (Table IV,
Figure la) revealed different effects on RNA expression in
the various cell lines. Most ECM RNAs were up-regulated in
the BxPC-3 cell line, but down-regulated in CAPAN-1 cells.
AsPC-l cells were unaffected by FCS deprivation. Some
ECM RNAs were selectively inducible or up-regulated by
incubation with FCS, e.g. collagen type I and type III in
PaCa44; fibronectin in BxPC-3; undulin in BxPC-3 and
PaCa-44; as well as laminin in CAPAN-2 and PANC-1
(Table IV, Figure la). Profound down-regulation by incuba-
tion with FCS was observed for collagen type I in PaCa-2,
and vitronectin and undulin in CAPAN-1 and PaCa-2, as
well as the laminin in CAPAN-1. Collagen type IV was
expressed at equal levels under both conditions (Table IV).
Table III RNA and protein levels of extracellular matrix proteins in human pancreatic tumours transplanted to nude mice
Collagen I Collagen II Collagen III Fibronectin Vitronectin Undulin Laminin
Tumour Grade RNA Protein RNA Protein RNA Protein RNA Protein RNA Protein RNA Protein RNA Protein
KLE 1 oa 1 2 2 1 2 2 2-3 2 1 2 1 2 2-3
PANK 1 0 3 2 2-3 2 2-3 2 3 2 2-3 2 2 2 2
PaCa-39 1 0 2-3 1 3 1 2-3 2 3 2 2-3 2 0 2 2-3
SCHU 1-2 oa 2-3 1 2-3 2 3 3 3 2 3 2 2-3 2 2-3
PaCa-2 3 oa 0 1 1 1 2 1 2-3 2 3 2 0 2 0
PaCa-3 3 oa 0 0 2 1 3 1 2-3 2 3 2 0 2 0
Fibroblasts 2 ND 3 ND 3 ND 3 ND 3 ND 3 ND 1 ND
Normal
pancreas 0 3 1 3 2 3 2 3 1 3 1 2 1 3
aTrace amounts of RNA (see Figure lb). ND, not done.148 M. LOHR et al.
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Figure 2 Immunofluorescent staining of ECM. a, Procollagen type I in cultured PANC-1 cells; b, collagen type III cultured
CAPAN-1 and c, PANC-1 cells; d, staining ofcollagen type IV in cultured PANC-1 cells; e, laminin in cultured PANC-1 cells. Bars
40 lm.
Discussion
Abundant production of ECM is one of the morphological
features of ductal adenocarcinomas of the pancreas. In this
study, we demonstrated that pancreatic carcinomas cells are
capable of synthesising and producing various ECM both in
vitro and in vivo and that this ECM expression can also be
modulated by presence or absence of fetal calf serum.
Although all pancreatic carcinoma cell lines synthesised
various ECM components, the ability to express the various
ECM mRNAs and proteins differed between the indivudal
tumour cell lines and nude mouse tumours.
The ECM detection system used in this study was
specifically constructed to recognise human ECM. Thus, the
cDNA probes were specific for human ECM under stringent
hybridisation and post-hybridisation conditions, as used in
our experiments, and the antibodies were specifically directed
against human ECM since no cross-reactivity with mouse
ECM was detected and most of them were pre-absorbed with
a mixture of rodent ECM by the manufacturers. Further-
more, on immunocytochemistry, the staining was localised to
the tumour cells. This was particularly easy to appreciate for
those ECM which were expressed at the interface of tumour
cells and on their luminal side where fibroblasts were absent.
In tissue culture, cells of apparent epithelial origin, as dem-
onstrated by their cytokeratin positivity, showed a mem-
branous or cytoplasmic staining for ECM which again
argued in favour of ECM production by the tumour cells
themselves. On phase-contrast and electron microscopy,
haematoxylin and eosin staining and immunofluorescence for
cytokeratin all cells of the pancreatic tumour cell lines proved
to be of epithelial origin (Rafiee et al., 1992). Fibroblasts
could not be observed. We conclude, therefore, that the
ECM detected in pancreatic tumour cell lines and xeno-
grafted nude mouse tumours are derived from the tumour
cells and not from contaminating or associated fibroblasts.
Figure 3 Immunocytochemical staining for laminin on grade I a,
(bar 40 1tm) and grade 3 b (bar 25 ltm) pancreatic tumours trans-
planted to nude mice (arrows). Note the negative staining of the
mouse connective tissue (open arrow).
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Figure 4 Immunocytochemical staining for collagen type III a
(bar 40 rum), vitronectin b (bar 40 gLm) and undulin c (bar 25 rim)
on the luminal/apical side of tumour cells (arrows) in addition to
the basement membrane side.
Whether in our system the host fibroblasts incorporated in
the xenografted tumours also produced ECM is unclear,
because neither our probes nor antibodies were specifically
directed against murine ECM. However, two other studies
with human lung, liver and colon carcinoma cell lines xeno-
grafted to nude mice demonstrated that host stromal cells as
well as epithelial cells contribute jointly to the ECM produc-
tion (Cleutjens et al., 1990; Damjanov et al., 1985).
Immunocytochemical and radioimmunological studies sug-
gest that laminin and hyaluran are produced by pancreatic
carcinoma cells (Haglund et al., 1984). However, no inter-
stitial matrix proteins such as collagen type III were detected
(Alitalo et al., 1981; Haberern & Kupchik, 1985) or inves-
tigated (Cleutjens et al., 1990). Our study confirms the
laminin production by pancreatic carcinoma cells in vivo and
in vitro and in addition showed that the tumour cells are able
to produce and synthesise other ECM which so far have not
been detected or investigated.
Of the interstitial ECM, many tumour cell lines and nude
mouse tumours expressed collagen type III and vitronectin,
at either the RNA or protein level, while only few cell lines
and tumours transcribed and produced undulin and fibronec-
tin. The fact that in an earlier study fibronectin could not be
detected in AsPC-l, PANC-1, CAPAN-1 and BxPC-3 cells
by the immunoperoxidase technique may be because of the
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use of antibody poorly characterised at that time (Haberern
& Kupchik, 1985).
Of the basement membrane components, collagen type IV
showed expression of mRNA and protein in almost all cell
lines and nude mouse tumours. In contrast, only a few cell
lines and tumours expressed the other basement membrane
constituent laminin, as has been shown before (Haberern &
Kupchik, 1985). This suggests that the synthesis and expres-
sion of two components of basal membrane ECM, laminin
and collagen type IV, are regulated independently. Major
disturbances in the regulation of the production of basement
membrane components in tumour cells may explain the com-
mon finding of a reduction or absence of basement memb-
ranes in carcinomas in vivo (Haglund et al., 1984; Liotta et
al., 1984; Kern et al., 1987). Alternatively, the defective basal
membrane composition could be due to a disturbed release of
laminin and collagen type IV from the tumour cells as a
response to the host stroma (Kallioninen et al., 1984) and/or
a selective extracellular proteolysis (Haberern & Kupchik,
1985; Barsky et al., 1983).
In several cell lines (e.g. CAPAN-1, CAPAN-2) there was
a discrepancy between the expression of some ECM (e.g.
collagen type III and vitronectin) at the RNA and protein
level. In case of a distinct RNA transcription but no or little
protein production, the most plausible explanation is a slow-
down of the post-translational synthesis of this matrix pro-
tein, as may occur under culture conditions. Alternatively,
the ECM may have been subjected to tumour-derived col-
lagenase activities, as described previously (Hooff, 1983;
Liotta et al., 1984; Zetter, 1990). However, there is so far.no
ready explanation for the reverse situation in which there was
protein expression without relevant RNA expression. The
possibility that such a constellation was due to rapid RNA
degradation can be largely excluded by the finding that a
concomitantly performed hybridisation with ribosomal RNA
(S138) revealed good signals in all instances. A high RNA
turnover rate of distinct ECM mRNA could be another
possibility.
The ECM expression pattern in the nude mouse tumours
revealed a correlation with the tumour grade for fibronectin
(RNA level), collagen type I and laminin (protein level). For
laminin such a correlation has already been described (Hag-
lund et al., 1984; Haberern-Blood et al., 1987). No clear
correlation of ECM expression with the grade of
differentiation was found in the tumour cell lines. This may
be due to the difference between the in vitro and in vivo
situation and could suggest that a stromal factor plays a role
in cellular differentiation (Hooff, 1983; Hall et al., 1990).
The luminal (apical) expression of collagen type III in
pancreatic tumour cells is a somewhat unexpected finding.
However, beside mucins naturally expressed on the apical
side of secretory epithelia (Haglund et al., 1986; Batge et al.,
1986), other non-mucinous proteins such as receptors for
transferrin and epidermal growth factor (EGF) have also
been found to be expressed on the luminal side of pancreatic
tumour cells in vivo (native carcinoma and nude mouse
model) (Kloppel, 1989; Chen et al., 1990).
Direct comparison between the in vitro and in vivo expres-
sion of ECM was possible for PaCa-2 and PaCa-3 (Kl6ppel
et al., 1985; Mai et al., 1990). Although we found identical
expression patterns for most ECM there were a few excep-
tions. The xenografts of PaCa-2 and PaCa-3 failed to express
undulin and laminin, but expressed substantial amounts of
collagen type IV and fibronectin at the protein level which
was not observed in vitro. This could indicate that host
factors, particularly the availability of external fibroblasts,
may stimulate the production of certain ECM in vivo (Cleut-
jens et al., 1990; Damjanov et al., 1985).
In a first attempt to investigate whether the expression of
ECM is constitutive or can be modulated principally by
means of growth-promoting factors, tumour cell lines were
cultured with and without fetal calf serum (FCS). In one cell
line, BxPC-3, RNA expression of all ECM tested, except
collagen type IV, was up-regulated by incubation with FCS.
In contrast, RNA expression of all ECM was found to be
decreased in the CAPAN-1 cell line when incubated with
FCS. In some other cell lines, ECM RNAs (particularly for
collagen type III) were partly up-regulated or down-
regulated. As FCS contains various growth factors and
cytokines such as EGF, transforming growth factor a, trans-
ferrin and interleukins, any of these may have had an effect
on ECM production in the tumour cell lines. Further
experiments are necessary to clarify the role of growth fac-
tors in the regulation of ECM (Longnecker et al., 1989;
Korc, 1991; Lemoine & Hall, 1990; Kalthoff et al., 1991).
In summary, we have demonstrated that cell lines and
xenografted tumours derived from human pancreatic ductal
adenocarcinomas are capable of synthesising and processing
a variety of ECM. To date, it is unclear whether this expres-
sion of ECM by tumour cells only serves to produce the
tumour stroma, or may also exert an effect on tumour cell
differentiation and, possibly, tumour cell growth. Recent data
on transmembrane connections between ECM and intracellu-
lar filaments suggesting a role for ECM in transducing signals
for regulation ofdifferentiation genes via cell membrane recep-
tors (integrins) lend support to the hypothesis of the co-
existence ofa structural and a humoral signal pathway (Singer,
1979; Hay, 1983; Bissell et al., 1982; Alberts et al., 1989).
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